MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Emotional, logistical and ethical aspects of voluntarily stopping eating and drinking in patients with movement disorders

    J. Shurer, M. Buchbinder, N. Browner (Chapel Hill, USA)

    Objective: We present two patients with atypical parkinsonism who chose to die by voluntarily stopping eating and drinking (VSED) to highlight the unique support and care needs associated…
  • MDS Virtual Congress 2021

    Visuo-cognitive training in Parkinson’s disease: Protocol for a randomised cross-over trial.

    J. Das, R. Morris, G. Barry, R. Walker, S. Stuart (Newcastle Upon Tyne, United Kingdom)

    Objective: To determine the feasibility and potential effects of a technological visuo-cognitive training (TVT) intervention in people with Parkinson’s (PwP). Background: Visual and cognitive impairments…
  • MDS Virtual Congress 2021

    Apomorphine Sublingual Film for “OFF” Episodes in Parkinson’s Disease: Impact of Concomitant Antiemetics on Nausea and Vomiting

    R. Hauser, S. Factor, W. Ondo, I. Zhang, E. Pappert, B. Navia (Tampa, USA)

    Objective: Analyze the effect of concomitant trimethobenzamide (TMB) on nausea and vomiting rates in patients with Parkinson’s disease (PD) receiving apomorphine sublingual film (APL) for…
  • MDS Virtual Congress 2021

    OPTI-ON: A Longitudinal Real-World Study of Opicapone in Patients with Parkinson’s Disease and Motor Fluctuations

    P. Lewitt, O. Klepitskaya, L. Bahroo, G. Liang, S. Rattana, J. Trotter, M. Serbin (West Bloomfield, USA)

    Objective: To conduct a longitudinal real-world study that examines treatment patterns, clinical outcomes, safety and tolerability of opicapone as an adjunctive treatment to carbidopa/levodopa (CD/LD)…
  • MDS Virtual Congress 2021

    Apomorphine Sublingual Film for “OFF” Episodes in Parkinson’s Disease: Analysis of Baseline Factors

    A. Nicholas, C. Singer, I. Zhang, E. Pappert, B. Navia (Birmingham, USA)

    Objective: Determine if baseline factors are associated with the apomorphine sublingual film (APL) dose required to achieve FULL “ON.” Background: APL is approved for the…
  • MDS Virtual Congress 2021

    The Impact of Visual Cueing on Gait Velocity in those with Parkinson’s Disease with Freezing of Gait

    M. Scavarda, K. Nagel, D. Peterson, K. Plesher, S. Moskowitz, C. Ivy, L. Denney (Phoenix, USA)

    Objective: To determine the ease of use and preliminary effectiveness of shoe-mounted visual cue (laser) on gait velocity in those with Parkinson’s Disease and freezing…
  • MDS Virtual Congress 2021

    Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson’s Disease

    M. Beke, P. Mackie, C. Rusch, E. Klann, A. Gurrala, S. Chua, E. Ince, L. Almeida, A. Ramirez-Zamora (Gainesville, USA)

    Objective: To investigate the effect of exogenous ketone ester supplementation on motor and non-motor symptoms in Parkinson’s Disease (PD). Background: Animal research and human pilot…
  • MDS Virtual Congress 2021

    Gut bacterial tyrosine decarboxylase as a predictive biomarker to identify Parkinson’s disease patients with motor fluctuations requiring frequent levodopa administration

    S. van Kessel, L. Verhagen Metman, G. Sanzo, P. Mcnamara, A. Keshavarzian, S. El Aidy (Groningen, Netherlands)

    Objective: To Investigate the clinical relevance of tyrosine decarboxylating (TDC)-bacteria in patients with Parkinson’s Disease (PD). Background: Recently, we have shown that TDC-gut bacteria that…
  • MDS Virtual Congress 2021

    Effects of low frequency repetitive transcranial stimulation over right dorsolateral prefrontal region on clinical symptoms and sleep structure of Parkinson’s disease Abstract

    WU. Jing, C. Jing, Z. Sheng, LIU. Feng (Suzhou, China)

    Objective: We aim to investigate the effects of low-frequency rTMS over the dorsolateral prefrontal cortex (DLPFC) on sleep and other symptoms in PD patients. Background:…
  • MDS Virtual Congress 2021

    Findings from a Community-based LOUD Crowd® Program for People with Parkinson Disease

    S. Parveen, A. Mandaville (Stillwater, USA)

    Objective: SPEAK OUT!® and LOUD Crowd® programs target the communicative functioning of people with Parkinson disease (PD). The current study includes findings from a year-long…
  • « Previous Page
  • 1
  • …
  • 46
  • 47
  • 48
  • 49
  • 50
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley